[144] QuantumScape Corporation SEC Filing

Rhea-AI Filing Summary

QuantumScape (QS) insider Form 144 notifies a proposed sale of 23,598 common shares (RSUs) through Fidelity, with an aggregate market value of $204,165.18 and 522,939,205 shares outstanding. The shares were acquired as RSUs on the same date indicated in the notice and the planned sale is listed for 08/19/2025 on the NYSE. The filer represents there is no undisclosed material adverse information. The filing also discloses four prior sales by the same account during the past three months totaling 1,151,428 shares for aggregate gross proceeds of $8,205,925.41.

Positive

• Transparent disclosure of a planned sale of 23,598 RSU-derived common shares with broker and market value specified
• Prior sales fully reported with dates, quantities, brokers, and gross proceeds, supporting regulatory transparency

Negative

• Insider sold 1,151,428 shares across four transactions in the past three months, generating $8,205,925.41 in gross proceeds

Insights

Securities Analyst

TL;DR: Routine insider RSU sale disclosure; prior quarter sales recorded but represent a small fraction of outstanding shares.

The Form 144 reports a planned sale of 23,598 RSU-derived common shares via Fidelity at an indicated aggregate market value of $204,165.18, with an approximate sale date of 08/19/2025 on the NYSE. The filer attests no undisclosed material adverse information. Recent dispositions by the same account total 1,151,428 shares for $8,205,925.41 in gross proceeds over four transactions in the past three months. Relative to 522,939,205 shares outstanding, these transactions represent a low single-digit basis-point ownership movement and appear to be individual liquidity events rather than large-scale dilution.

Corporate Governance Expert

TL;DR: Filing aligns with Rule 144 disclosure practices; transparency is in line with insider reporting expectations.

The notice shows acquisition of the securities as RSUs and a contemporaneous plan to sell them through a broker, consistent with standard reporting under Rule 144. The signature representation affirms no undisclosed material adverse facts. The document lists prior insider sales and specifies broker, share counts, and proceeds, providing clear traceability. There is no indication in this filing of trading plan adoption dates or other 10b5-1 specifics, so no inference about pre-established trading arrangements can be drawn from this notice alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	23598	204165.18	522939205	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU	QUANTUMSCAPE			23598	08/19/2025	RSU

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mohit Singh c/o Quantumscape Corporation 1730 Technology Dr San Jose CA 95110	Common Stock	05/19/2025	71428	315318.91
Mohit Singh c/o Quantumscape Corporation 1730 Technology Dr San Jose CA 95110	Common Stock	06/25/2025	290000	1727675.00
Mohit Singh c/o Quantumscape Corporation 1730 Technology Dr, San Jose CA 95110	Common Stock	06/26/2025	325000	2343607.50
Mohit Singh c/o Quantumscape Corporation 1730 Technology Dr San Jose CA 95110	Common Stock	07/08/2025	465000	3819324.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being sold in the QS Form 144?

The filing lists 23,598 shares of common stock derived from RSUs to be sold through Fidelity with an aggregate market value of $204,165.18.

When is the approximate sale date listed for the QS shares?

The Form 144 indicates an approximate sale date of 08/19/2025 on the NYSE.

How were the securities acquired according to the filing?

The securities were acquired as RSUs on the same date shown in the notice and the payment/nature is listed as RSU.

Has the filer sold other QS shares recently?

Yes. The filing discloses four sales in the past three months totaling 1,151,428 shares for aggregate gross proceeds of $8,205,925.41.

What does the filer represent about undisclosed information?

By signing, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.